Endothelial Function and Cardiovascular Disease: Advances and Challenges
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (15 April 2024) | Viewed by 478
Special Issue Editors
Interests: atherosclerosis; cardiovascular disease; pharmacology; natural products
Special Issues, Collections and Topics in MDPI journals
Interests: hemodynamic shear stress and the endothelium in the process of atherosclerosis; the role of Hippo pathway in cardiovascular regulation; the endocrine function of endothelium in health and disease; identification of new biomarker(s) for early diagnosis of atherosclerotic vascular disease; identification of new compounds for atherosclerosis prevention and treatment; inter-organ crosstalk and physical exercise
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, due to the emergence of RNA sequencing (RNA-Seq), single-cell RNA-seq, secretome profiling, lipidomics, metabolomics, etc., great strides have been made in our understanding of the important role of endothelial dysfunction in various types of cardiovascular disease (CVD). These biotechnological advances enable us to decipher the heterogeneity of endothelial cells, smooth muscle cells and immune cells and unravel their unique roles in CVD, as well as assisting in the discovery of novel biomarkers of CVD. Beyond traditional lipid-lowering therapies such as statins exerting pleiotropic effects on endothelial cells, anti-inflammatory therapies with anti-interleukin 1 beta, colchicine and anti-interleukin 6 have marked the concept of “anti-inflammation therapy in atherosclerosis” as a reality. These anti-inflammatory therapies prevent CVD partially via preventing endothelial dysfunction. Endothelial cells safeguard vascular health by secreting vasoactive molecules, including nitric oxide, to maintain the vascular tone and anti-thrombotic interface. Once they have become dysfunctional, endothelial cells lose their capacity to maintain vascular homeostasis, leading to augmented inflammation, oxidative stress, constriction, leukocyte adhesion, endothelial–mesenchymal transition and senescence. Targeted therapies against these aspects of endothelial dysfunction hold promise for treating CVD. This Special Issue is devoted to the use of advanced technologies to understand the pathomechanisms of endothelial dysfunction in CVD, and to the discovery of novel targeted therapies. Topics of interest include, but are not limited to, new therapeutic targets in endothelial dysfunction, nutraceuticals in preventing endothelial dysfunction and novel biomarkers of endothelial dysfunction. Preclinical, clinical and translational studies related to endothelial dysfunction and CVD are welcome for submission to this Special Issue. In addition, experimental and bioinformatics papers and up-to-date review articles related to endothelial function and CVD are also welcome.
Dr. Suowen Xu
Dr. Li Wang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- endothelial (dys)function
- multiomics
- therapies
- inflammation
- mechanobiology
- endothelial homeostasis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
